News on Pharmacology continually updated from thousands of sources around the net.
2 hrs ago | Chemical and Engineering News
A natural compound found in turmeric has shown promise as a potential treatment for Alzheimer's disease but delivering it to the brain has been a challenge.
Could you survive the end of civilization?
Should public schools teach Evolution or Creationism?
3 hrs ago | PR-inside.com
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions and financing in the pharmaceutical and healthcare market.
" Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues" authored by Susan S. Schiffman, PhD, an internationally known sweetener researcher and Kristina I. Rother, MD, MHSc, of the National Institutes of Health , summarizes the biological properties of sucralose based on hundreds of archival, peer-reviewed scientific ... (more)
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found.
As the debate about electronic cigarette regulation continues with the U.S. Food and Drug Administration and device manufacturers, data from one state poses concerns that should be part of the conversation.
Manufacturers, scientists, and regulators are examining methods for characterizing nanomaterials in drug formulation and production and the need for clear US and international standards in this area.
National Institutes of Health Director Francis S. Collins, M.D., Ph.D, announced the selection of Philip E. Bourne, Ph.D., as the first permanent Associate Director for Data Science .
Its lead product is an optimized intranasal delivery form of carbetocin, a synthetic analog of the naturally occurring peptide hormone, oxytocin.
Active targeting of nanoparticles has been exploited as a means to increase the therapeutic efficacy of NP-based drugs by promoting their delivery to cellular sites of action."
From the Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA ; Vascular Surgery Research, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA ; Department of Hypertension and Vascular Disease, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China ; Department of Cardiology and Center of ... (more)
Bridgepoint Development Capital has acquired Quotient Clinical , a provider of early stage drug development services, from the Quotient Bioresearch Group.
Based in Cambridge, UK, Ario Pharma is a spin out from Xention Pharma Ltd, a specialist ion channel R&D company.
The following statement will be published in the journal, Food and Chemical Toxicology , alongside a selection of letters to the editors regarding the decision to retract the paper by Seralini et al. .
NLG919 is a small-molecule, orally bioavailable, immune checkpoint inhibitor designed to counteract a fundamental mechanism by which tumors evade immune-mediated destruction.
Duke Medicine, DURHAM, N.C. - Researchers at Duke Medicine conclude that high cholesterol may make breast cancer worse when they found that a byproduct of cholesterol functions like the hormone estrogen, leading to increases in the growth and spread of breast cancer.
What's more, patients must often try several different SSRI medications, each with a different set of side effects, before finding one that is effective.